Skip to content

SB 190 · Pennsylvania · 2025-2026 · Billy

Skip to content

Home
/
Bills
/
Pennsylvania
/
2025-2026
/
SB 190

Pennsylvania · 2025-2026 session · senate

SB 190An Act providing for pharmaceutical transparency; establishing the Pharmaceutical Transparency Review Board and providing for its powers and duties; establishing the Pharmaceutical Transparency Review Fund; and imposing a penalty.

Status: In committee
Latest action: 2025-01-29 — Referred to Banking & Insurance
Primary sponsor: Sharif Street (Democratic)

Track this bill

Sponsors

Sharif Street (Democratic) · primaryprimary
Timothy Kearney · cosponsor
Vincent Hughes (Democratic) · cosponsor
Jay Costa (Democratic) · cosponsor

Public legislative record via Billy. Sign in to track, annotate, and export work product.

About public bill pages Compare Billy Pennsylvania bill RSS

John Kane (Democratic) · cosponsor

JSJudith Schwank · cosponsor

DLDaniel Laughlin · cosponsor

Maria Collett (Democratic) · cosponsor

Versions

Printer's No. PN0140—

Legislative history

Jan 29, 2025
Referred to Banking & Insurance

Official sources

Version 0PDF HTML DOCX

About this page

Is this the official Pennsylvania bill page?: No — this is Billy’s public legislative record for SB 190. Official source links are listed above when publishers provide them.
Can I track updates?: Yes. Sign in to track SB 190, get alerts, annotate diffs, and export Word work product.